In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia maps CVD, diabetes and kidney disease panorama

This article was originally published in Clinica

Executive Summary

Australia has published what is being billed as the "first systematic approach" to monitoring and addressing risk factor prevention related to cardiovascular disease (CVD), diabetes and chronic kidney disease (CKD). A report published today by health advisory body, the Australian Institute for Health and Welfare (AIHW), provides details of a panorama that has resulted in these three conditions accounting for around a quarter of the burden of all disease and just under two-thirds of all deaths.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045005

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel